DCF — PLAINS REGIONAL MEDICAL CTR - CLOVIS
Enterprise Value: $-43.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-43.2M
Enterprise Value
$-16.7M
PV of Cash Flows
$-26.5M
PV of Terminal Value
$-42.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $116.7M | $-1.0M | -1.0% | $-6.0M | $-5.4M |
| Year 2 | $120.3M | $0.1M | 0.0% | $-5.0M | $-4.1M |
| Year 3 | $123.9M | $1.4M | 1.0% | $-3.9M | $-2.9M |
| Year 4 | $127.6M | $2.0M | 2.0% | $-3.4M | $-2.3M |
| Year 5 | $131.4M | $2.4M | 2.0% | $-3.1M | $-1.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-43.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$113.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.013950423143305503
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5